Abstract

A prospective study of 1969 patients with intermittent claudication receiving placebo medication for a minimum of 1 year is reported. Patients were carefully monitored and only four patients were lost to follow-up. Annual mortality was 4.3%. Thirty-six patients developed a definite myocardial infarction, 27 a major stroke, 32 required a major amputation and 111 required surgical or radiological intervention for deteriorating ischaemia of the leg. The entry characteristics of the patients were analysed as a predictor of serious cardiovascular events. The most sensitive predictors of total mortality were age, history of coronary heart disease and an ankle/arm pressure ratio below 0.5. Of the laboratory measurements performed only the initial white cell count was a significant predictor of myocardial infarction, stroke and vascular deaths.

Keywords

MedicineStroke (engine)Myocardial infarctionProspective cohort studyClaudicationAmputationAnkleCardiologyInternal medicineSurgeryPhysical therapyVascular diseaseArterial disease

MeSH Terms

AmputationSurgicalCerebrovascular DisordersDouble-Blind MethodFemaleHumansIntermittent ClaudicationMaleMiddle AgedMyocardial InfarctionPlacebosProportional Hazards ModelsProspective StudiesRisk Factors

Affiliated Institutions

Related Publications

Publication Info

Year
1991
Type
article
Volume
5
Issue
2
Pages
131-133
Citations
231
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

231
OpenAlex
4
Influential
156
CrossRef

Cite This

John Dormandy, Gordon Murray (1991). The fate of the claudicant—a prospective study of 1969 claudicants. European Journal of Vascular Surgery , 5 (2) , 131-133. https://doi.org/10.1016/s0950-821x(05)80676-0

Identifiers

DOI
10.1016/s0950-821x(05)80676-0
PMID
2037083

Data Quality

Data completeness: 86%